Apr 27, 2015 at 08:28 | Source: Moneycontrol.com
Analysts are mixed on the Vishal Sikka-led company with most brokerages still betting on it but slashed target price and earnings per share (EPS) estimates.
Apr 24, 2015 at 18:55 | Source: Moneycontrol.com
Brokerage house ICICIdirect.com has recommended investors to subscribe to UFO Moviez India IPO for listing gains, in its research report dated April 24, 2015.
Apr 24, 2015 at 14:43 | Source: Moneycontrol.com
Brokerage house Prabhudas Lilladher is bullish on HCL Technologies and has recommended 'Accumulate' rating on the stock with a target price of Rs 970, in its research report dated April 21, 2015.
Apr 24, 2015 at 14:37 | Source: Moneycontrol.com
Brokerage house Prabhudas Lilladher is bullish on ACC and has recommended 'Buy' rating on the stock with a target price of Rs 1800, in its research report dated March 16, 2015.
Apr 24, 2015 at 11:24 | Source: Moneycontrol.com
Operationally, it was a tough quarter for Cairn India with oil prices falling 29% QoQ and Rajasthan oil production slipping 3% QoQ on challenges in Bhagyam field.
Apr 23, 2015 at 17:50 | Source: Moneycontrol.com
Shares of Tata Steel surged 5 percent intraday after Bank of America Merill Lynch reinstated coverage with a buy rating. The brokerage has set a target price of Rs 500 per share valuing the company at its five-year average P/B of 1.1x one-year forward P/E of 8x.
Apr 23, 2015 at 10:00 | Source: Moneycontrol.com
The brokerage believes improved production, price hike potential and an attractive dividend yield, adds up to a fairly compelling investment thesis for Coal India's stock.
Apr 22, 2015 at 14:49 | Source: Moneycontrol.com
The brokerage expects voice revenue per minute (RPM) to decline by 1 percent quarter-on-quarter Q4FY15, due to a cut in interconnect charges (IUC) from March 1. However, the cut should also aid an improvement in EBITDA margins, as the interconnect cost will also come down, it adds.
Apr 22, 2015 at 12:31 | Source: Moneycontrol.com
The brokerage believes base business of Sun Pharma can grow at 15 percent over the medium term, hence, sees significant upside from the integration of the Ranbaxy acquisition, manufacturing related synergies and the potential for accretive bolt-on M&A.
Apr 22, 2015 at 09:12 | Source: CNBC-TV18
Deutsche Equities sees the ongoing tactical correction as a healthy consolidation & investors, who had been on the sidelines may use this opportunity to realign portfolios. Deutsche maintained its year-end Sensex target of 33,000.